Barry, who retired from the NBA in 2009, recalled that a few days before our sit-down he “drove out to the Clippers’ practice facility, wearing sneakers and board shorts, just to get my basketball fix in. Between games I pick up a ball and start shooting. In the back of my mind I’m thinking, You’re 42, man; can you still? So I get a rebound, do a little power dribble in the paint and, sure enough, throw it down. I put the ball down and walked out. I can still do that. That’s good.”
The boundary for stopping the trial owing to the lack of evidence of a difference between treatments at a P value of 0.05 was crossed (Figure 5 in the Supplementary Appendix). There were no significant differences between the groups in the rate of death at 28 days or in the rates of death in the ICU, in the hospital, at 6 months, or at 12 months (Table 2). Kaplan–Meier curves for estimated survival showed no significant differences in the outcome (Figure 2). Cox proportional-hazards analyses that included the APACHE II score, sex, and other relevant variables yielded similar results (Figure 6 in the Supplementary Appendix). There were more days without need for the trial drug and more days without need for open-label vasopressors in the norepinephrine group than in the dopamine group, but there were no significant differences between the groups in the number of days without need for ICU care and in the number of days without need for organ support (Table 3). There were no significant differences in the causes of death between the two groups, although death from refractory shock occurred more frequently in the group of patients treated with dopamine than in the group treated with norepinephrine (P=0.05).
“There’s something about dunking a basketball that lures us in,” he said, reflecting on his first jam, during lunch period his sophomore year at De La Salle High in Concord, Calif., back when his driver’s license read 5' 11", 112 pounds. “It stokes the imagination. It’s something you always dream of doing. I have a friend whose father, at age 50, is trying to dunk.”
The simplest method to measure an athlete's vertical jump is to get the athlete to reach up against a flat wall, with a flat surface under his/her feet (such as a gym floor or concrete) and record the highest point he/she can reach flat-footed (the height of this point from the ground is referred to as "standing reach"); fingertips powdered with chalk can facilitate the determination of points touched on the wall. The athlete then makes an effort to jump up with the goal of touching the highest point on the wall that he or she can reach; the athlete can perform these jumps as many times as needed. The height of the highest point the athlete touches is recorded. The difference between this height and the standing reach is the athlete's vertical jump.
×